US pharmaceutical giant Pfizer will expand its line of drugs and therapies with the takeover of $17 billion Hospira. The deal has been approved by the boards of both companies, and will importantly add Hospira's portfolio of sterile injectable treatments and biosimilar drugs to Pfizer's broad pharmaceutical offerings.
Pfizer will pay $90 a share in cash for Hospira, which is nearly 40 percent premium.
Reckitt Benckiser to Spin Off Its US-Based Pharmaceuticals Arm
Reckitt Benckiser (RB), British household goods firm has decided to spin off its US-based pharmaceuticals division, it announced after a strategic review.
Advertisement
The companies said, "The market for sterile injectables, injectable drugs which can treat a range of maladies from pain to cancer, will be about $70 billion in 2020. The world market for biosimilars, officially approved adaptations of off-patent drugs made by others, will hit $20 billion in 5-years."
Pfizer said, "Hospira's product line strategically complements its own and will add a growing international revenue stream."
Pfizer chairman and chief executive Ian Read said, "Hospira's business aligns well with our new commercial structure and is an excellent strategic fit for our Global Established Pharmaceutical business, which will benefit from a significantly enhanced product portfolio in growing markets."
Source: Medindia
Pfizer chairman and chief executive Ian Read said, "Hospira's business aligns well with our new commercial structure and is an excellent strategic fit for our Global Established Pharmaceutical business, which will benefit from a significantly enhanced product portfolio in growing markets."
Source: Medindia
Crab Shells Yields Pharmaceuticals
Generally, mould fungi are not pleasant; however they can now be used as `chemical factories`.
Advertisement
 Pharmaceutical Advances Offer New Options for Health Outcomes At Digestive Disease WeekAt Digestive Disease Week® (DDW), research presented explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C. | Advertisement
|
Polymorphic Forms in Pharmaceutical Compounds Highlighted by New Technology
State-of-the-art nuclear magnetic resonance techniques have been used by scientists at the University of Warwick to shed new light on how pharmaceutical molecules pack together in the solid state
Advertisement
Recommended Reading
Latest Drug News
New discoveries about aspirin's interplay between messenger molecules that are crucial in the inflammatory proves again that it is a powerful anti-inflammatory drug.
The new drug target sheds insights into strategies to fight drug-resistant S. pneumoniae, stated research.
The effectiveness of adding fludrocortisone to hydrocortisone vs hydrocortisone alone among patients with septic shock was analyzed using target trial emulation.
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.